Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew L. Laccetti
Andrew L. Laccetti
University of Texas MD Anderson Cancer Center
Medicine
Prostate cancer
Oncology
Internal medicine
Immunotherapy
5
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial.
2021
Journal of Clinical Oncology
Chung-Han Lee
Martin H. Voss
Maria I. Carlo
Ying-Bei Chen
Eduard Reznik
Andrea Knezevic
Robert A. Lefkowitz
Natalie Shapnik
Diana Tassone
Chloe Dadoun
Neil J. Shah
Colette Owens
Deaglan Joseph McHugh
David H. Aggen
Andrew L. Laccetti
Ritesh Kotecha
Darren R. Feldman
Robert J. Motzer
Show All
Source
Cite
Save
Citations (5)
Combination anti-angiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes.
2019
Journal of Clinical Oncology
Andrew L. Laccetti
Minas P. Economides
Aradhana M. Venkatesan
Jianjun Gao
Eric Jonasch
Paul G. Corn
Amado J. Zurita
Nizar M. Tannir
Pavlos Msaouel
Amishi Yogesh Shah
Matthew T. Campbell
Show All
Source
Cite
Save
Citations (0)
Establishing a prostate cancer referral pathway between urology and medical oncology at Lyndon B. Johnson Hospital.
2019
Journal of Clinical Oncology
Andrew Wiele
Helen Ajufo
Joshua Michael Gulvin
Andrew L. Laccetti
Sarah Brown
Leslie Stapleton
Sarah H Rizvi
Anne Park
Hilary Y. Ma
Alyssa G. Rieber
Show All
Source
Cite
Save
Citations (0)
Remote patient monitoring using smart phone derived patient reported outcomes and Fitbit data to enable longitudinal predictive modeling in prostate cancer: Feasibility results and lessons on platform development.
2019
Journal of Clinical Oncology
Andrew L. Laccetti
Rebecca Slack-Tidwell
Nipa Sheth
Christopher J. Logothetis
Michael VanAlstine
Show All
Source
Cite
Save
Citations (1)
Immunotherapy for metastatic prostate cancer: Immuno-cold or the tip of the iceberg?
2017
Current Opinion in Urology
Andrew L. Laccetti
Sumit K. Subudhi
Show All
Source
Cite
Save
Citations (11)
1